Daily biotech dealflow + market tape in 5 minutes — for VC, BD&L, and public biotech investors.
Dec 24, 2025
•
1 min read
Dynavax lands in Sanofi’s cart, oral Wegovy gets the green light, and Medicare pricing carve-outs loom.
Dec 23, 2025
Oral GLP-1 gets an FDA greenlight, CMS floats new pricing demos, and Shionogi drops $2.5B on ALS.
Dec 22, 2025
Cytokinetics lands a first approval, BioMarin goes big, and drug pricing deals widen their footprint.
Dec 19, 2025
Regeneron sets an Eylea-biosimilar launch window; Ipsen’s FOP readout flops; policy hawks eye China.
Dec 18, 2025
BioNTech closes CureVac, schizophrenia cash pours in, and FDA clears a twice-yearly asthma biologic.
Dec 17, 2025
GSK gets an asthma win, Alvotech taps convertibles, and Sanofi lands EU orphan status in emphysema.
